129 related articles for article (PubMed ID: 37852240)
1. Synthesis and Bioevaluation of 2-Styrylquinoxaline Derivatives as Tau-PET Tracers.
Wu N; Zhang L; Zhang X; Zhang Q; Liu J; Li Y; Yan XX; Liang Y; Zhang J; Cui M
Mol Pharm; 2023 Nov; 20(11):5865-5876. PubMed ID: 37852240
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents.
Zhou K; Yang F; Li Y; Chen Y; Zhang X; Zhang J; Wang J; Dai J; Cai L; Cui M
Mol Pharm; 2021 Mar; 18(3):1176-1195. PubMed ID: 33475377
[TBL] [Abstract][Full Text] [Related]
3. [
Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
[TBL] [Abstract][Full Text] [Related]
4. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and bioevaluation of technetium-99 m / rhenium labeled phenylquinoxaline derivatives as Tau imaging probes.
Yang F; Wang K; Zhou K; Dai B; Dai J; Liang Y; Cui M
Eur J Med Chem; 2019 Sep; 177():291-301. PubMed ID: 31158745
[TBL] [Abstract][Full Text] [Related]
6. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Tago T; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
J Nucl Med; 2016 Feb; 57(2):208-14. PubMed ID: 26541774
[TBL] [Abstract][Full Text] [Related]
7. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with
Lohith TG; Bennacef I; Vandenberghe R; Vandenbulcke M; Salinas CA; Declercq R; Reynders T; Telan-Choing NF; Riffel K; Celen S; Serdons K; Bormans G; Tsai K; Walji A; Hostetler ED; Evelhoch JL; Van Laere K; Forman M; Stoch A; Sur C; Struyk A
J Nucl Med; 2019 Jan; 60(1):107-114. PubMed ID: 29880509
[No Abstract] [Full Text] [Related]
8. Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease.
Lerdsirisuk P; Harada R; Hayakawa Y; Shimizu Y; Ishikawa Y; Iwata R; Kudo Y; Okamura N; Furumoto S
Nucl Med Biol; 2021 Feb; 93():11-18. PubMed ID: 33221641
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel oxindole derivatives for imaging neurofibrillary tangles in Alzheimer's disease.
Watanabe H; Ono M; Kimura H; Matsumura K; Yoshimura M; Okamoto Y; Ihara M; Takahashi R; Saji H
Bioorg Med Chem Lett; 2012 Sep; 22(17):5700-3. PubMed ID: 22832319
[TBL] [Abstract][Full Text] [Related]
10. Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease.
Okamura N; Suemoto T; Furumoto S; Suzuki M; Shimadzu H; Akatsu H; Yamamoto T; Fujiwara H; Nemoto M; Maruyama M; Arai H; Yanai K; Sawada T; Kudo Y
J Neurosci; 2005 Nov; 25(47):10857-62. PubMed ID: 16306398
[TBL] [Abstract][Full Text] [Related]
11. Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles.
Hostetler ED; Walji AM; Zeng Z; Miller P; Bennacef I; Salinas C; Connolly B; Gantert L; Haley H; Holahan M; Purcell M; Riffel K; Lohith TG; Coleman P; Soriano A; Ogawa A; Xu S; Zhang X; Joshi E; Della Rocca J; Hesk D; Schenk DJ; Evelhoch JL
J Nucl Med; 2016 Oct; 57(10):1599-1606. PubMed ID: 27230925
[TBL] [Abstract][Full Text] [Related]
12. Computational Insight into the Binding Profile of the Second-Generation PET Tracer PI2620 with Tau Fibrils.
Kuang G; Murugan NA; Zhou Y; Nordberg A; Ågren H
ACS Chem Neurosci; 2020 Mar; 11(6):900-908. PubMed ID: 32069017
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of N, O-Benzamide difluoroboron derivatives as near-infrared fluorescent probes to detect β-amyloid and tau tangles.
Chen Y; Ouyang Q; Li Y; Zeng Q; Dai B; Liang Y; Chen B; Tan H; Cui M
Eur J Med Chem; 2022 Jan; 227():113968. PubMed ID: 34752954
[TBL] [Abstract][Full Text] [Related]
14. Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain.
Cai L; Qu B; Hurtle BT; Dadiboyena S; Diaz-Arrastia R; Pike VW
ACS Chem Neurosci; 2016 Jul; 7(7):897-911. PubMed ID: 27171905
[TBL] [Abstract][Full Text] [Related]
15. Discovery and preclinical characterization of [
Kroth H; Oden F; Molette J; Schieferstein H; Capotosti F; Mueller A; Berndt M; Schmitt-Willich H; Darmency V; Gabellieri E; Boudou C; Juergens T; Varisco Y; Vokali E; Hickman DT; Tamagnan G; Pfeifer A; Dinkelborg L; Muhs A; Stephens A
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2178-2189. PubMed ID: 31264169
[TBL] [Abstract][Full Text] [Related]
16. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.
Mohammadi Z; Alizadeh H; Marton J; Cumming P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830659
[TBL] [Abstract][Full Text] [Related]
17. Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease.
Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
J Nucl Med; 2016 Apr; 57(4):608-14. PubMed ID: 26697966
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Characterization of the Tau PET Tracer [
Harada R; Lerdsirisuk P; Shimizu Y; Yokoyama Y; Du Y; Kudo K; Ezura M; Ishikawa Y; Iwata R; Shidahara M; Ishiki A; Kikuchi A; Hatano Y; Ishihara T; Onodera O; Iwasaki Y; Yoshida M; Taki Y; Arai H; Kudo Y; Yanai K; Furumoto S; Okamura N
J Nucl Med; 2023 Sep; 64(9):1495-1501. PubMed ID: 37321821
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of
Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
